Company Overview - Andersen Group is targeting a valuation of up to $1.75 billion in its initial public offering (IPO) in the US [1] - The company filed a registration statement with the US Securities and Exchange Commission (SEC) in September 2025 to list its shares on the New York Stock Exchange (NYSE) under the symbol ANDG [1] - The IPO aims to offer 11 million shares at an estimated price range between $14 and $16 per share, with the goal of raising up to $176 million [1] Underwriting and Management - A thirty-day option will be available for underwriters to buy as many as 1,650,000 additional shares at the IPO price, excluding underwriting fees and commissions [2] - Morgan Stanley and UBS Investment Bank have been appointed as lead book-running managers for this offering [2] - Deutsche Bank Securities, Truist Securities, and Wells Fargo Securities are also involved as book-running managers, while Baird and William Blair are listed as additional book-running managers [2] Business Operations - Andersen Group operates in the US with a focus on tax, valuation, and financial advisory services for individuals, family offices, business entities, and alternative investment funds [3] - The company's network extends internationally through member and collaborating firms delivering tax, legal, valuation, and consulting services in more than 180 countries at over 1,000 sites, employing upwards of 3,000 partners and 50,000 staff [3] Historical Context - The firm's background is linked to the closure of Arthur Andersen in 2002 following its involvement with Enron, which was convicted of obstruction of justice related to the Enron case, although this conviction was later overturned by the Supreme Court [4] - After Arthur Andersen ceased operations, HSBC acquired a portion of its tax division through Wealth & Tax Advisory Services (WTAS), which subsequently separated from HSBC in a management buyout before adopting the Andersen Tax name in 2014 [4] - This rebranding marked the start of what is now known as Andersen Group [5]

Core Viewpoint - Michael Burry, a prominent money manager, holds significant positions in Fannie Mae and Freddie Mac common stock, believing that a re-listing of these housing-finance giants is imminent [1][2]. Company Insights - Burry has expressed a bullish outlook on Fannie Mae and Freddie Mac, citing political and regulatory challenges that must be addressed for a public offering to take place [1][4]. - He personally owns substantial amounts of both companies' common stock and is analyzing the political dynamics and potential valuation in a future sale [3]. - Shares of Fannie Mae and Freddie Mac have seen notable gains, with Fannie Mae rising 3.9% and Freddie Mac climbing 3.1% recently, contributing to over a 15% increase in value this month [3]. Regulatory Considerations - For a public offering to occur, Burry argues that regulators need to relax capital requirements, convert certain preferred shares into common stock, and reduce the government's claim on the companies, as the current claims render common shares "worthless" [4]. - Burry acknowledges that significant challenges remain before an IPO can be realized for both companies [4].

Core Viewpoint - Investor Michael Burry holds significant positions in Fannie Mae and Freddie Mac, indicating a bullish outlook on their potential re-listing and future performance [1][5]. Group 1: Investment Position - Michael Burry has a sizable stake in both Fannie Mae and Freddie Mac common stock, reflecting confidence in their future prospects [5][8]. - The shares of Fannie Mae and Freddie Mac have shown volatility, with Fannie Mae rising by 2% and Freddie Mac by 2.4% on December 8, and both have increased approximately 12% since late November [5]. Group 2: IPO Challenges and Projections - Burry outlines several challenges that must be addressed for the IPOs of Fannie Mae and Freddie Mac, including easing capital requirements, converting preferred shares to common stock, and reducing government claims on the companies [6]. - He anticipates that the IPOs could be priced at 1x to 1.25x times the book value, with potential trading at 1.5x to 2x times the book value within 1-2 years post-listing [6]. Group 3: Market Dynamics and Support - Burry notes that without government withdrawal, the common shares of Fannie Mae and Freddie Mac are essentially "worthless," highlighting the need for regulatory changes [6]. - There is speculation that Berkshire Hathaway may take a substantial position in the upcoming IPOs, as Warren Buffett's company previously held a stake in Fannie Mae [7].

Core Viewpoint - Michael Burry has taken sizable positions in Fannie Mae and Freddie Mac, indicating a bullish outlook on these mortgage finance giants as they may return to public markets, which he refers to as "Toxic Twins No More" [1][2][5] Group 1: Investment Thesis - Burry projects that an IPO for Fannie Mae and Freddie Mac could price shares between 1 and 1.25 times book value [2] - He anticipates that once listed, shares could trade at 1.5 to 2 times book value within one to two years, expecting natural growth acceleration post-IPO [3] - The investment marks a significant shift for Burry, who previously warned about the GSEs' fragility and past failures, including the 2008 crisis [4] Group 2: Market Context - Burry speculates that Berkshire Hathaway could take a substantial position in Fannie Mae and Freddie Mac if they go public, as Berkshire previously held stakes in these companies before the 2008 crash [6] - The potential IPOs align with reports that the Trump administration may launch them later this year, with Fannie and Freddie currently guaranteeing approximately 62% of outstanding U.S. mortgages [7]

Core Insights - The Mills family, founders of Medline, sold a majority stake to private equity in 2021 for $30 billion, but their remaining stake is now valued at $6 billion to $7 billion, contributing to a total estimated net worth of $20 billion for the family [1][2][3] - Medline is preparing for a significant IPO this winter, potentially valued at up to $55 billion, marking it as a major event in the market [1] - The company's sales have surged to $25.5 billion in 2024, an 83% increase from $13.9 billion five years prior, with profits rebounding to $1.2 billion [8] Company Background - Medline was founded in 1910 by A.L. Mills, initially selling butcher's aprons before transitioning to medical supplies after a request from a local hospital seamstress [5] - The company has a history of innovation, including the introduction of the first surgeon's gown with 360-degree coverage and the commercialization of specific fabrics to reduce glare in operating rooms [5] Recent Developments - The Mills family established a family office called Council Ring Capital after the 2021 sale and began stepping back from day-to-day operations in 2023 [3][7] - Jim Boyle became the first non-family CEO of Medline in October 2023, indicating a shift in leadership dynamics [7] - Medline's role in the pandemic response was significant, distributing medical supplies to nursing homes, pharmacies, and 45% of hospital systems nationwide [6]

Investor Michael Burry, known for "The Big Short," said on Monday he owns sizable positions in Fannie Mae and Freddie Mac and expects them to rise materially if the U.S. mortgage finance giants are ta... ...

Key Points Madrone Advisors acquired 75.8 million shares, valued at over $1.2 billion. The holding now represents 62.8% of Madrone's 13F reportable assets under management. The new position is now Madrone's largest holding. These 10 stocks could mint the next wave of millionaires › What happened Madrone Advisors, LLC initiated a new stake in StubHub (NYSE:STUB), according to a quarterly Form 13F filed with the Securities and Exchange Commission on Nov. 14, 2025 (SEC filing). The filing shows Mad ...

As filed with the Securities and Exchange Commission on December 8, 2025. Registration No. 333-290366 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ________________________ Silicon Valley Acquisition Corp. (Exact name of registrant as specified in its charter) ________________________ Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Cla ...

Core Viewpoint - Elon Musk refuted claims that SpaceX is raising funds at an $800 billion valuation, stating that such reports are inaccurate [1] Group 1: Financial Performance - SpaceX has generated positive cash flow for several years and conducts stock buybacks biannually to allow employees and investors to sell shares instead of raising new capital [2] - The company's rising valuation is attributed to advancements in Starship and Starlink, as well as securing global direct-to-cell spectrum, which expands its market potential [2] Group 2: Business Developments - SpaceX filed a "STARLINK MOBILE" trademark in October, indicating potential plans for mobile network carrier operations [3] - Musk stated that with Starship, SpaceX is expected to carry approximately 99% of Earth's orbital payload mass once it begins frequent launches, even if competitors increase their launch rates [3] Group 3: IPO Plans - SpaceX, which has remained private for nearly 25 years, has indicated a potential IPO target for late 2026 [4] - Musk expressed interest in taking SpaceX public to provide Tesla supporters the opportunity to own shares of the company, despite acknowledging potential drawbacks [4]

SpaceX is preparing to sell insider shares in a transaction that would value Elon Musk’s rocket and satellite maker at as much as $800 billion, people familiar with the matter said, reclaiming the title of the world’s most valuable closely held company. SpaceX is exploring a possible initial public offering as soon as late next year, one of the people said. The details, discussed by SpaceX’s board of directors on Thursday at its Starbase hub in Texas, could change based on interest from insider sellers an ...